Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 131

Similar articles for PubMed (Select 23532526)

1.

Treatment of acute posterior uveitis in a porcine model by injection of triamcinolone acetonide into the suprachoroidal space using microneedles.

Gilger BC, Abarca EM, Salmon JH, Patel S.

Invest Ophthalmol Vis Sci. 2013 Apr 3;54(4):2483-92. doi: 10.1167/iovs.13-11747.

PMID:
23532526
2.

Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model.

Chen M, Li X, Liu J, Han Y, Cheng L.

J Control Release. 2015 Apr 10;203:109-17. doi: 10.1016/j.jconrel.2015.02.021. Epub 2015 Feb 17.

PMID:
25700623
3.

Ocular distribution and toxicity of intravitreal injection of triamcinolone acetonide in normal equine eyes.

Yi NY, Davis JL, Salmon JH, Gilger BC.

Vet Ophthalmol. 2008 Sep;11 Suppl 1:15-9. doi: 10.1111/j.1463-5224.2008.00636.x.

PMID:
19046265
4.

Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.

Ding X, Li J, Hu X, Yu S, Pan J, Tang S.

Retina. 2011 May;31(5):838-45. doi: 10.1097/IAE.0b013e3181f4420d.

PMID:
21293319
5.

Glycyrrhizin could reduce ocular hypertension induced by triamcinolone acetonide in rabbits.

Song Z, Gong Y, Liu H, Ren Q, Sun X.

Mol Vis. 2011;17:2056-64. Epub 2011 Aug 4.

6.

Effect of choroidal perfusion on ocular tissue distribution after intravitreal or suprachoroidal injection in an arterially perfused ex vivo pig eye model.

Abarca EM, Salmon JH, Gilger BC.

J Ocul Pharmacol Ther. 2013 Oct;29(8):715-22. doi: 10.1089/jop.2013.0063. Epub 2013 Jul 3.

PMID:
23822159
7.

Vitreous pharmacokinetics and retinal safety of intravitreal preserved versus non-preserved triamcinolone acetonide in rabbit eyes.

Oliveira RC, Messias A, Siqueira RC, Bonini-Filho MA, Haddad A, Damico FM, Maia-Filho A, Crispim PT, Saliba JB, Ribeiro JA, Scott IU, Cunha-Jr AS, Jorge R.

Curr Eye Res. 2012 Jan;37(1):55-61. doi: 10.3109/02713683.2011.593722. Epub 2011 Oct 26.

PMID:
22029458
8.

Posterior subtenon and intravitreal triamcinolone acetonide for diabetic macular edema.

Ozdek S, Bahçeci UA, Gürelik G, Hasanreisoğlu B.

J Diabetes Complications. 2006 Jul-Aug;20(4):246-51.

PMID:
16798476
10.

Intravitreal vs. subtenon triamcinolone acetonide for the treatment of diabetic cystoid macular edema.

Cellini M, Pazzaglia A, Zamparini E, Leonetti P, Campos EC.

BMC Ophthalmol. 2008 Mar 17;8:5. doi: 10.1186/1471-2415-8-5.

11.

Intravitreal triamcinolone acetonide injection for the treatment of posterior uveitis.

Ozkiris A.

Ocul Immunol Inflamm. 2006 Aug;14(4):233-8.

PMID:
16911985
12.
13.

[Effect of intravitreal and orbital floor triamcinolone acetonide injection on intraocular inflammation in patients with active non-infectious uveitis].

Roesel M, Gutfleisch M, Heinz C, Heimes B, Zurek-Imhoff B, Heiligenhaus A.

Klin Monbl Augenheilkd. 2009 Feb;226(2):110-4. doi: 10.1055/s-2008-1027762. Epub 2009 Feb 10. German.

PMID:
19206044
14.

Preparation, characterization, and in vivo evaluation of triamcinolone acetonide microspheres after intravitreal administration.

Zarei-Ghanavati S, Malaekeh-Nikouei B, Pourmazar R, Seyedi S.

J Ocul Pharmacol Ther. 2012 Oct;28(5):502-6. Epub 2012 Apr 26.

PMID:
22537291
15.
16.

Biodegradable intrascleral implant of triamcinolone acetonide in experimental uveitis.

Shin JP, Park YC, Oh JH, Lee JW, Kim YM, Lim JO, Kim SY.

J Ocul Pharmacol Ther. 2009 Jun;25(3):201-8. doi: 10.1089/jop.2008.0086.

PMID:
19456254
17.

Retinal toxicity of intravitreal triamcinolone acetonide at high doses in the rabbit.

Ruiz-Moreno JM, Montero JA, Bayon A, Rueda J, Vidal M.

Exp Eye Res. 2007 Feb;84(2):342-8. Epub 2006 Dec 1.

PMID:
17141760
18.

Intraocular pressure elevation following triamcinolone acetonide administration as related to administration routes.

Hirano Y, Ito T, Nozaki M, Yasukawa T, Sakurai E, Yoshida M, Ogura Y.

Jpn J Ophthalmol. 2009 Sep;53(5):519-22. doi: 10.1007/s10384-009-0692-5. Epub 2009 Oct 22.

PMID:
19847609
19.

Targeted administration into the suprachoroidal space using a microneedle for drug delivery to the posterior segment of the eye.

Patel SR, Berezovsky DE, McCarey BE, Zarnitsyn V, Edelhauser HF, Prausnitz MR.

Invest Ophthalmol Vis Sci. 2012 Jul 1;53(8):4433-41. doi: 10.1167/iovs.12-9872.

20.

Outcome of intravitreal triamcinolone in uveitis.

Kok H, Lau C, Maycock N, McCluskey P, Lightman S.

Ophthalmology. 2005 Nov;112(11):1916.e1-7. Epub 2005 Sep 19.

PMID:
16171868
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk